Princeton

From 2007.igem.org

(Difference between revisions)
 
(5 intermediate revisions not shown)
Line 7: Line 7:
=[[Princeton/Project Description | An RNAi-Enhanced Logic Circuit: Cancer-Specific Detection and Destruction]]=
=[[Princeton/Project Description | An RNAi-Enhanced Logic Circuit: Cancer-Specific Detection and Destruction]]=
-
The [[Princeton/People | Princeton University iGEM 2007 team]], consisting of 10 undergraduate students, 2 high school students, and 8 instructors, envisions a paradigm shift in the way one can target cancer and destroy the resulting cancerous cells.
+
The [[Princeton/People | Princeton University iGEM 2007 team]], consisting of 10 undergraduate students, 2 high school students, and 7 instructors, envisions a paradigm shift in the way one can target cancer and destroy the resulting cancerous cells.
-
Using standard engineering practices, we have designed, and are in the process of implementing, a novel system that utilizes RNA interference (RNAi) to detect and destroy cancer cells in a tissue-specific manner. We are interfacing RNAi components together with promoter and repressor elements to form logic circuits, which allow the use of multiple criteria to target cancerous cells in a unique and highly specific manner. As a measure of safety, we utilize mutant lentiviral integrase to deliver our construct into the cell as a non-integrated plasmid, preventing any disruptive effects that could be attributed to pseudorandom integration by the lentivirus. This also ensures that the daughter cells will not inherit the cancer-detecting circuitry, thus preventing unintended proliferation of our construct and allow for more extensive and comprehensive cancer treatments.
+
Using standard engineering practices, we have designed, and are in the process of implementing, a novel system that utilizes RNA interference (RNAi) to detect and destroy cancer cells in a tissue-specific manner. We are interfacing RNAi components together with promoter and repressor elements to form logic circuits, which allow the use of multiple criteria to target cancerous cells in a unique and highly specific manner. As a measure of safety, we utilize mutant lentiviral integrase to deliver our construct into the cell as a non-integrated plasmid, preventing any disruptive effects that could be attributed to pseudorandom integration by the lentivirus. This also ensures that the daughter cells will not inherit the cancer-detecting circuitry, thus preventing unintended proliferation of our construct and allow for more extensive and comprehensive cancer treatments. We have constructed many components of our system and are in the process of testing our plasmids in a proof of concept manner. Where possible, we will revise and improve upon our components based on mathematical modeling and experimental results.  
-
 
+
-
We have constructed many components of our system and are in the process of testing our plasmids in a proof of concept manner. Where possible, we will revise and improve upon our components based on mathematical modeling and experimental results.  [[Princeton/lab | Lab work]], including [[Princeton/lab/experimentation | experimentation]], [[Princeton/lab/bioinformatics | bioinformatics]], and [[Princeton/lab/simulation | simulations]], and [[Princeton/literature | literature]] have been used as feedback mechanisms to improve the implementation of the designed systems.
+
Please see the [[Princeton/overview | extended overview]] for more information.
Please see the [[Princeton/overview | extended overview]] for more information.
Line 18: Line 16:
|-valign="top"
|-valign="top"
|width=179.25px style="padding: 5px; background-color: #ffffaa; border: 2px solid #993300;" |
|width=179.25px style="padding: 5px; background-color: #ffffaa; border: 2px solid #993300;" |
 +
<h3>Team Members</h3>
-
<center><h3>Team members</h3></center>
+
*[[user:asichel|Andrew Sichel]]   
-
 
+
*[[user:aswamina|Aparna Swaminathan]]
-
*[[user:aatreya|Anand Atreya]]   
+
*[[user:btsui|Bambi Tsui]]
-
*[[user:bgeer|Bashir Geer]]
+
*[[user:cdehart|Caroline DeHart]]
*[[user:cdehart|Caroline DeHart]]
 +
*[[user:dcooper|Devin Cooper]]
 +
*[[user:jmonk|Jon Monk]]
*[[user:jchiu|Justine Chiu]]
*[[user:jchiu|Justine Chiu]]
-
*[[user:jmangual|John Mangual]]
+
*[[user:katias|Katia Sherman]]
-
*[[user:loughlin|Robert Loughlin]]
+
*[[user:kmangal|Kush Mangal]]
-
*[[user:okhowash|Oly Khowash]]
+
*[[user:nyuan|Neal Yuan]]
-
*[[user:rkamal|Ritu Kamal]]
+
*[[user:pcowgill|Paul Cowgill]]
-
*[[user:sgoli|Sanjiv Goli]]
+
*[[user:vichij|Vichi Jagannathan]]
-
*[[user:smomen|Safiyy Momen]]
+
-
*[[user:sriutta|Stephen Riutta]]
+
-
*[[user:tedtlee|Ted Lee]]
+
-
*[[user:weiho|Wei Ho]]
+
-
*[[user:asichel|Andrew Sichel]]
+
-
<center><h3>Instructors</h3></center>
+
|width=179.25px style="padding: 5px; background-color: #ffffaa; border: 2px solid #993300;" |
-
*[[user:rweiss|Ron Weiss]] [http://www.princeton.edu/~rweiss Website]
+
<h3>Instructors</h3>
-
*[[user:ilemischka|Ihor Lemischka]] [http://www.molbio.princeton.edu/research_facultymember.php?id=25 Website]
+
 
 +
*[[user:rweiss|Ron Weiss]] [mailto:rweiss@princeton.edu Contact Ron] [http://www.princeton.edu/~rweiss Website]
*[[user:Cil|Cil Purnick]] [mailto:ppurnick@princeton.edu Contact Cil]
*[[user:Cil|Cil Purnick]] [mailto:ppurnick@princeton.edu Contact Cil]
-
*[[user:cry707|Christoph Schaniel]]
+
*[[user:ilemisch|Ihor Lemischka]] [http://directory.mssm.edu/faculty/facultyInfo.php?id=43268&deptid=92 Website]
-
*[[user:sairams|Sairam Subramanian]]
+
*[[user:cry707|Christoph Schaniel]] [http://directory.mssm.edu/faculty/facultyInfo.php?id=43270&deptid=92 Website]
-
*[[user:eandrian|Ernesto Andrianantoandro]]
+
*[[user:pguye|Patrick Guye]]
-
*[[user:firsing|Steve Firsing]]
+
*[[user:eskamoah|Noah Davidsohn]]
-
*[[user:leor|Leor Weinberger]]
+
*[[user:saurabhg|Saurabh Gupta]]
-
|width=179.25px style="padding: 5px; background-color: #ffffaa; border: 2px solid #993300;" |
+
<h3>Resources</h3>
 +
[[Princeton/literature | Literature on RNAi and Cancer]]
-
<center><h3>[[Princeton:Week One Agenda | Week 1 Agenda]]</h3>
+
<h3>Pictures</h3>
-
<h3>[[Princeton:Week Two Agenda | Week 2 Agenda]]</h3>
+
[[Princeton/People | Our happy team]]
-
<h3>[[Princeton:Week Three Agenda | Week 3 Agenda]]</h3>
+
-
<h3>[[Princeton:Week Four Agenda | Week 4 Agenda]]</h3>
+
-
<h3>[[Princeton:Week Five Agenda | Week 5 Agenda]]</h3>
+
-
<h3>[[Princeton:Week Six Agenda  | Week 6 Agenda]]</h3>
+
-
<h3>[[Princeton:Week Seven Agenda | Week 7 Agenda]]</h3>
+
-
<h3>[[Princeton:Group Calendar|Group Calendar]]</h3>
+
-
 
-
<h3>Research</h3></center>
 
|width=179.25px style="padding: 5px; background-color: #ffffaa; border: 2px solid #993300;" |
|width=179.25px style="padding: 5px; background-color: #ffffaa; border: 2px solid #993300;" |
 +
<h3>Overview</h3>
 +
[[Princeton/overview | Our Project]]
 +
<h3>Lab Work</h3>
 +
[[Princeton/lab | Lab work]]
-
<center><h3>Resources</h3></center>
+
<h3>Research</h3>
-
 
+
[[Princeton/lab/experimentation | Experimentation]]
-
==Overview==
+
-
=[[Princeton/Project Description | <center>An RNAi-Enhanced Logic Circuit: Cancer-Specific Detection and Destruction]] =
+
-
 
+
-
The [[Princeton/People | Princeton University iGEM 2007 team]], consisting of 10 undergraduate students, 2 high school students, and 8 instructors, envisions a paradigm shift in the way one can target cancer and destroy the resulting cancerous cells.
+
-
 
+
-
Using standard engineering practices, we have designed, and are in the process of implementing, a novel system that utilizes RNA interference (RNAi) to detect and destroy cancer cells in a tissue-specific manner. We are interfacing RNAi components together with promoter and repressor elements to form logic circuits, which allow the use of multiple criteria to target cancerous cells in a unique and highly specific manner. As a measure of safety, we utilize mutant lentiviral integrase to deliver our construct into the cell as a non-integrated plasmid, preventing any disruptive effects that could be attributed to pseudorandom integration by the lentivirus. This also ensures that the daughter cells will not inherit the cancer-detecting circuitry, thus preventing unintended proliferation of our construct and allow for more extensive and comprehensive cancer treatments.
+
-
 
+
-
We have constructed many components of our system and are in the process of testing our plasmids in a proof of concept manner. Where possible, we will revise and improve upon our components based on mathematical modeling and experimental results.  [[Princeton/lab | Lab work]], including [[Princeton/lab/experimentation | experimentation]], [[Princeton/lab/bioinformatics | bioinformatics]], and [[Princeton/lab/simulation | simulations]], and [[Princeton/literature | literature]] have been used as feedback mechanisms to improve the implementation of the designed systems.
+
-
 
+
-
Please see the [[Princeton/overview | extended overview]] for more information.
+
-
 
+
 +
<h3>Bioinformatics</h3>
 +
[[Princeton/lab/bioinformatics | Bioinformatics]]
-
==Previous work==
+
<h3>Simulations</h3>
-
Click [[Princeton:Project Summary|here for a summary of Princeton's iGEM2006 project]]
+
[[Princeton/lab/simulation | Simulations]]

Latest revision as of 03:48, 27 October 2007


2007 logo Group picture

An RNAi-Enhanced Logic Circuit: Cancer-Specific Detection and Destruction

The Princeton University iGEM 2007 team, consisting of 10 undergraduate students, 2 high school students, and 7 instructors, envisions a paradigm shift in the way one can target cancer and destroy the resulting cancerous cells.

Using standard engineering practices, we have designed, and are in the process of implementing, a novel system that utilizes RNA interference (RNAi) to detect and destroy cancer cells in a tissue-specific manner. We are interfacing RNAi components together with promoter and repressor elements to form logic circuits, which allow the use of multiple criteria to target cancerous cells in a unique and highly specific manner. As a measure of safety, we utilize mutant lentiviral integrase to deliver our construct into the cell as a non-integrated plasmid, preventing any disruptive effects that could be attributed to pseudorandom integration by the lentivirus. This also ensures that the daughter cells will not inherit the cancer-detecting circuitry, thus preventing unintended proliferation of our construct and allow for more extensive and comprehensive cancer treatments. We have constructed many components of our system and are in the process of testing our plasmids in a proof of concept manner. Where possible, we will revise and improve upon our components based on mathematical modeling and experimental results.

Please see the extended overview for more information.

Team Members

Instructors

Resources

Literature on RNAi and Cancer

Pictures

Our happy team

Overview

Our Project

Lab Work

Lab work

Research

Experimentation

Bioinformatics

Bioinformatics

Simulations

Simulations